Cargando…

Atherosclerotic plaque vulnerability is increased in mouse model of lupus

Anti-apolipoprotein A-1 (anti-apoA-1 IgG) and anti-double stranded DNA (anti-dsDNA IgG) autoantibodies have been described as mediators of atherogenesis in mice and humans. In the present study, we aim to investigate the association between atherosclerotic parameters, autoantibodies and plaque vulne...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santiago-Raber, Marie-Laure, Montecucco, Fabrizio, Vuilleumier, Nicolas, Miteva, Kapka, Baptista, Daniela, Carbone, Federico, Pagano, Sabrina, Roth, Aline, Burger, Fabienne, Mach, Francois, Brandt, Karim J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591560/ https://www.ncbi.nlm.nih.gov/pubmed/33110193 http://dx.doi.org/10.1038/s41598-020-74579-8

Ejemplares similares

Anti-Apolipoprotein A-1 IgG Influences Neutrophil Extracellular Trap Content at Distinct Regions of Human Carotid Plaques
por: da Silva, Rafaela F., et al.
Publicado: (2020)

Epitope of antiphospholipid antibodies retrieved from peptide microarray based on R39‐R43 of β2‐glycoprotein I
por: Moghbel, Marc, et al.
Publicado: (2022)

Single-Cell Analysis Uncovers Osteoblast Factor Growth Differentiation Factor 10 as Mediator of Vascular Smooth Muscle Cell Phenotypic Modulation Associated with Plaque Rupture in Human Carotid Artery Disease
por: Brandt, Karim J., et al.
Publicado: (2022)

NLRP3 Inflammasome Activation Controls Vascular Smooth Muscle Cells Phenotypic Switch in Atherosclerosis
por: Burger, Fabienne, et al.
Publicado: (2021)

Single-Cell RNA-Seq Reveals a Crosstalk between Hyaluronan Receptor LYVE-1-Expressing Macrophages and Vascular Smooth Muscle Cells
por: Burger, Fabienne, et al.
Publicado: (2022)

Cardiotrophin-1 Deficiency Abrogates Atherosclerosis Progression
por: Miteva, Kapka, et al.
Publicado: (2020)

The E3 Ubiquitin Ligase Peli1 Deficiency Promotes Atherosclerosis Progression
por: Burger, Fabienne, et al.
Publicado: (2022)

Follicular regulatory helper T cells control the response of regulatory B cells to a high-cholesterol diet
por: Burger, Fabienne, et al.
Publicado: (2020)

Intraplaque Expression of C-Reactive Protein Predicts Cardiovascular Events in Patients with Severe Atherosclerotic Carotid Artery Stenosis
por: Bonaventura, Aldo, et al.
Publicado: (2016)

The Immune Response Is Involved in Atherosclerotic Plaque Calcification: Could the RANKL/RANK/OPG System Be a Marker of Plaque Instability?
por: Montecucco, Fabrizio, et al.
Publicado: (2007)

Insulin Resistance: A Proinflammatory State Mediated by Lipid-Induced Signaling Dysfunction and Involved in Atherosclerotic Plaque Instability
por: Montecucco, Fabrizio, et al.
Publicado: (2008)

Update on the Pathophysiological Role of Intracellular Signaling Pathways in Atherosclerotic Plaques and Ischemic Myocardium
por: Montecucco, Fabrizio, et al.
Publicado: (2012)

Impact of Alirocumab on Release Markers of Atherosclerotic Plaque Vulnerability in Patients with Mixed Hyperlipidemia and Vulnerable Atherosclerotic Plaque
por: Kosowski, Michał, et al.
Publicado: (2022)

Atherosclerotic Plaque Biomarkers: Beyond the Horizon of the Vulnerable Plaque
por: W. van Lammeren, Guus, et al.
Publicado: (2011)

Osteopontin and osteoprotegerin in atherosclerotic plaque – are they significant markers of plaque vulnerability?
por: Strobescu-Ciobanu, Cristina, et al.
Publicado: (2020)

Ultrasound Tissue Characterization of Vulnerable Atherosclerotic Plaque
por: Picano, Eugenio, et al.
Publicado: (2015)

Nuclear Molecular Imaging for Vulnerable Atherosclerotic Plaques
por: Lee, Soo Jin, et al.
Publicado: (2015)

Coronary Atherosclerotic Vulnerable Plaque: Current Perspectives
por: Stefanadis, Christodoulos, et al.
Publicado: (2017)

Immune-Mediated Inflammation in Vulnerable Atherosclerotic Plaques
por: Mangge, Harald, et al.
Publicado: (2019)

Calcification in Atherosclerotic Plaque Vulnerability: Friend or Foe?
por: Shi, Xuan, et al.
Publicado: (2020)

Colchicine reduces atherosclerotic plaque vulnerability in rabbits
por: Roubille, François, et al.
Publicado: (2021)

Vulnerable Atherosclerotic Plaque: Is There a Molecular Signature?
por: Chiorescu, Roxana Mihaela, et al.
Publicado: (2022)

Correlation Between Calcification Characteristics of Carotid Atherosclerotic Plaque and Plaque Vulnerability
por: Xu, Xiangli, et al.
Publicado: (2021)

Prognostic and therapeutic considerations of antibodies against c‐ter apolipoprotein A‐1 in the general population
por: Vuilleumier, Nicolas, et al.
Publicado: (2020)

Molecular Imaging of Vulnerable Atherosclerotic Plaques in Animal Models
por: Gargiulo, Sara, et al.
Publicado: (2016)

BIRC6 Is Associated with Vulnerability of Carotid Atherosclerotic Plaque
por: Alloza, Iraide, et al.
Publicado: (2020)

Small entities with large impact: microcalcifications and atherosclerotic plaque vulnerability
por: Hutcheson, Joshua D., et al.
Publicado: (2014)

The role of near-infrared spectroscopy in the detection of vulnerable atherosclerotic plaques
por: Horvath, Martin, et al.
Publicado: (2016)

Lectin Pathway of Complement Activation Is Associated with Vulnerability of Atherosclerotic Plaques
por: Fumagalli, Stefano, et al.
Publicado: (2017)

Establishment of a Novel Mouse Model for Atherosclerotic Vulnerable Plaque
por: Wang, Xueyu, et al.
Publicado: (2021)

Vulnerable atherosclerotic plaque features: findings from coronary imaging
por: Kurihara, Osamu, et al.
Publicado: (2021)

Current advances in the imaging of atherosclerotic vulnerable plaque using nanoparticles
por: Zhang, Ming, et al.
Publicado: (2022)

Non-Invasive Modalities in the Assessment of Vulnerable Coronary Atherosclerotic Plaques
por: Theofilis, Panagiotis, et al.
Publicado: (2022)

cGAS-STING Pathway Performance in the Vulnerable Atherosclerotic Plaque
por: Wan, Xueqi, et al.
Publicado: (2022)

Atherosclerotic plaque vulnerability quantification system for clinical and biological interpretability
por: Zhang, Ge, et al.
Publicado: (2023)

Cholesterol in human atherosclerotic plaque is a marker for underlying disease state and plaque vulnerability
por: Chen, Zhu, et al.
Publicado: (2010)

Mast cells in vulnerable atherosclerotic plaques – a view to a kill
por: Lindstedt, Ken A, et al.
Publicado: (2007)

Is Cadmium Exposure Associated with the Burden, Vulnerability and Rupture of Human Atherosclerotic Plaques?
por: Bergström, Göran, et al.
Publicado: (2015)

Effects of Serum Lipid Smoothness on the Progression and Vulnerability of Atherosclerotic Plaques in Rabbits
por: Zou, Xiao, et al.
Publicado: (2014)

Ultrasonography of vulnerable atherosclerotic plaque in the carotid arteries: B-mode imaging
por: Fedak, Andrzej, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tooeooh6tf5bd6uqlp1o3s8d4t